Bard Associates’s Anixa Biosciences ANIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-51,200
| Closed | -$59K | – | 180 |
|
|
2017
Q2 | $59K | Hold |
51,200
| – | – | 0.03% | 173 |
|
|
2017
Q1 | $154K | Hold |
51,200
| – | – | 0.07% | 160 |
|
|
2016
Q4 | $276K | Sell |
51,200
-1,600
| -3% | -$8.63K | 0.13% | 130 |
|
|
2016
Q3 | $205K | Sell |
52,800
-3,200
| -6% | -$12.4K | 0.1% | 149 |
|
|
2016
Q2 | $176K | Sell |
56,000
-4,800
| -8% | -$15.1K | 0.09% | 149 |
|
|
2016
Q1 | $183K | Hold |
60,800
| – | – | 0.11% | 140 |
|
|
2015
Q4 | $183K | Hold |
60,800
| – | – | 0.11% | 135 |
|
|
2015
Q3 | $289K | Buy |
+60,800
| New | +$289K | 0.17% | 119 |
|